Hardware Podcasts

027 - "Become a Historian of the Problem" with Duane Mancini

Let's Combinate · 6 Apr 2022 · 59m

What this episode covers

Duane Mancini, CEO and Managing Partner of Project Medtech, discusses his transition from medicinal chemistry to medical device regulatory strategy at NAMSA and LabCorp. He explains the critical importance of integrating reimbursement strategy early in the development of combination products to avoid commercialization failures, noting that regulatory choices like 510(k) can negatively impact reimbursement pathways. Mancini details how Project Medtech supports startups through its podcasts, Startup Symposiums, and consulting services, focusing on capital raising, milestone mapping, and navigating the complexities of drug-device combinations like insulin patches.

Most relevant to

early-stage companies

Topics

Mentioned

Companies
Project Medtech, NAMSA, LabCorp, Galaxy Data, Green Light Guru, Mimic, Icorp Vascular, MetaView, University Hospital Ventures, Cleveland Clinic
Products
Medtech Money

Related episodes from other shows

Other shows on the same ground, closest first.

  • Global Medical Device Podcast · 30m

    Building a Startup in the MedTech Industry

    Duane Mancini, president and founder of Project Medtech, explains why MedTech startups must integrate reimbursement, regulatory, and clinical strategies from the outset to avoid costly rework and ensure investor confidence. He argues that while regulatory approval (such as 510(k), De Novo, or PMA pathways) is necessary, it is not sufficient for commercial success, as market access and reimbursement determine whether a device can actually be sold. Mancini emphasizes that a robust Quality Management System (QMS) is critical for startups aiming for acquisition by larger strategics, who often reject deals with poor quality infrastructure. He also highlights the importance of building a strong team and advisory board, noting that investors bet on the team's ability to execute a holistic go-to-market plan rather than just the product itself.

    Validation & product-market fitCertification & compliance
    7 chapters

  • Global Medical Device Podcast · 36m

    How to Establish a Solid Foundation for Fundraising and Product Success by Focusing on Regulatory

    Isabella Schmitt, a regulatory affairs consultant at Proxima Clinical Research, joins host John Spear to discuss how a strong regulatory strategy underpins fundraising and product success for medical device companies. Schmitt advises startups to avoid starting with technology without a clear problem, emphasizing the importance of Minimum Viable Products (MVPs) and design controls to prevent perpetual iteration. She highlights the '1/10/100 rule' to illustrate how early validation reduces costs and increases company value by hitting major milestones like animal studies or clinical trials. The conversation also covers selecting regulatory pathways (PMA vs. 510(k)) based on market size and reimbursement, and navigating current global regulatory landscapes like the EU MDR and FDA requirements.

    Validation & product-market fitFundraising & investors
    8 chapters

  • Global Medical Device Podcast · 43m

    Building Your Regulatory Strategy for Commercialization

    Duane Mancini, CEO and Managing Partner at Project Medtech, advises early-stage medtech founders on integrating regulatory strategy with fundraising and commercialization. He emphasizes that investors prioritize the team and the problem over the product, and warns founders to avoid 'bad' investors who may force premature exits. Mancini highlights that commercialization requires addressing three key hospital stakeholders: clinicians (especially nurses), patient outcomes, and economic benefit, while building a robust Quality Management System (QMS) early to maximize valuation for potential strategic acquisitions.

    Fundraising & investorsValidation & product-market fit
    10 chapters

  • Global Medical Device Podcast · 39m

    #465: Why Good Medical Devices Fail: Reimbursement Strategy with Ali Samiian

    Ali Samiian, founder of Popular Access Advisors, explains why medical device companies fail commercially by treating reimbursement as a post-FDA paperwork exercise rather than a core product strategy. He details how product design, clinical trial endpoints, and regulatory pathways (such as 510(k) vs. De Novo) must align with payer requirements for durable medical equipment (DME) or other categories to ensure coverage. Samiian highlights the importance of demonstrating durability, standard-of-care comparisons, and value to the healthcare system to secure appropriate pricing from CMS and private payers.

    Validation & product-market fitPricing, margins & unit economics
    9 chapters

  • Global Medical Device Podcast · 30m

    #451: Building a MedTech Powerhouse: The 5 Stages of Founder Success

    Etienne Nichols, host of the Global Medical Device Podcast, outlines the five stages of building a medical device company, emphasizing that success depends on hiring the right specialized experts at each phase rather than just having good technology. He argues that regulatory strategy must precede prototyping to avoid wasting capital on designs that don't meet FDA requirements, citing a founder who lost $400,000 on a prototype before realizing a PMA pathway was needed. Nichols details the specific roles required for design controls, testing, submission, and commercialization, warning that the 'valley of death' often occurs after clearance due to a lack of reimbursement strategy.

    Medical & health devicesCertification & compliance
    1 chapters

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Let's Combinate. The episode itself belongs to its publisher.